An institutional conflict of interest (institutional COI) happens when an organization’s own financial interests (or those of its top officials) could bias, or appear to bias, its decisions, research, or services.

What is an institutional COI?

  • It involves the institution (e.g., university, hospital, research center), not just an individual staff member.
  • The risk is that the institution’s financial stake may influence, or seem to influence, how it designs, conducts, oversees, or reports activities such as research, teaching, or clinical care.
  • These financial interests can come from investments, gifts, royalty income, exclusive contracts, or large donations from companies that do business with the institution.

A clear example of an institutional COI

One commonly used example in university settings is:

  • A university is considering a major research partnership with a pharmaceutical company that has previously made large donations to the university’s endowment, funding buildings, scholarships, or labs.
  • A senior university official involved in approving the partnership also holds significant stock in that same pharmaceutical company.
  • Because both the university and the official stand to gain financially if the company’s products or research succeed, there is a risk that:
    • Research questions might be framed to favor the company’s products.
    • Negative results might be downplayed or delayed.
    • The institution’s oversight of safety or data integrity could be compromised, or appear compromised, to protect the relationship.

This situation is an example of an institutional COI because the financial interests of the institution and its leaders are directly tied to the commercial partner whose products or research are under the institution’s control or evaluation.

Another concrete example in practice

  • A university hospital owns equity in a medical device company whose devices are being tested in clinical trials at that same hospital.
  • The hospital also receives large licensing royalties from technology it licensed to that company.
  • When the hospital’s clinicians run trials on that device, any positive results may increase the value of the company, and therefore the hospital’s investment and royalty stream, creating a serious institutional COI around patient safety and research integrity.

Typical sources of institutional COI

Common institutional financial interests that can create COI include:

  • Equity or ownership stakes in a company (public or private) that sponsors or is affected by the institution’s research.
  • Large gifts or donations from companies or foundations that also sponsor research or have contracts with the institution.
  • Royalty streams and other earnings from intellectual property that is being tested or used in institutional research or clinical care.
  • Exclusive contracts with industry—for example, agreeing to use only one company’s products in research labs or clinics.

How institutions usually manage these COIs

Many universities and academic medical centers have formal institutional COI policies and committees that:

  • Require disclosure of institutional financial interests and senior officials’ related interests.
  • Review potential COIs and decide whether they must be reduced, managed, or eliminated (e.g., divesting equity, changing roles of officials, or declining certain studies).
  • Sometimes move oversight to an independent body or another institution’s review board when the conflict is especially serious, especially in human-subjects research.

Bottom note: Information gathered from public forums or data available on the internet and portrayed here.